MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Post by RISKMANAGEMENTon Nov 19, 2007 12:12pm

243 Views

Post# 13830126

MedMira to settle debt with 10-cent shares

MedMira to settle debt with 10-cent shares - News Release Dr. James Smith reports MEDMIRA ANNOUNCES SETTLEMENT OF DEBT MedMira Inc. has reached an agreement with one supplier and two debtholders to settle $685,000 owing for debts and services rendered to the company through the issuance of common shares. Of the total debt, $600,000 is to a non-arm's-length party. The company will issue 6.85 million common shares at a price of 10 cents per share subject to the approval of the TSX Venture Exchange. We seek Safe Harbor.

Bullboard Posts

Thematic Insights report: The Hard Asset Century